Funding round
OpenEvidence Series D
OpenEvidence, which works in medical information search engine development in Miami, raised $250M in a Series D round announced on 6 Apr 2026, led by Thrive Capital and DST Global, at a $12.00B post-money valuation. 19 firms took part. It is OpenEvidence's fourth venture round on record; the one before was a Series C in Oct 2025.
$250M
Amount raised
$12.00B
Post-money valuation
$11.75B pre-money
19
Investors
2 leads
2.0x
Step-up from the Series C
$6.00B in Oct 2025
2.1%
Stake sold
new money over the post-money
Valuation
What this round says about the price
This round priced OpenEvidence at $12.00B after the new money, 2.0 times the $6.00B of its Series C (Oct 2025). The $250M bought investors about 2.1% of the company. It came 6 months after OpenEvidence's Series C. It is 34% of the $735M OpenEvidence has raised in the venture rounds on record. No later venture round is on record for OpenEvidence.
OpenEvidence's funding rounds
OpenEvidence has 4 venture rounds on record. This one is highlighted.
Investors
Who put money in
Thrive Capital and DST Global led the round with 17 other firms.
Lead investors
- Thrive Capital backs 130 venture-backed companies new investor
- DST Global backs 179 venture-backed companies new investor
Also in the round
- Sequoia Capital backs 589 venture-backed companies new investor
- GV backs 428 venture-backed companies new investor
- NVIDIA new investor
- Kleiner Perkins backs 285 venture-backed companies new investor
- Blackstone backs 83 venture-backed companies new investor
- KKR backs 104 venture-backed companies new investor
- Coatue backs 229 venture-backed companies new investor
- backs 44 venture-backed companies new investor
- ICONIQ new investor
- Greycroft backs 236 venture-backed companies new investor
- Breyer Capital backs 85 venture-backed companies new investor
- BOND backs 91 venture-backed companies new investor
- Craft Ventures backs 197 venture-backed companies new investor
- Goanna new investor
- Meritech Capital backs 84 venture-backed companies new investor
- Alkeon backs 51 venture-backed companies new investor
- Mayo Clinic new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development, scaling operations and working capital.
- Product development
- Scaling operations
- Working capital
Comparable rounds
How it compares
84 Series D rounds in Tech Companies within a year either side disclosed an amount; the median was $102M, and this round was 2.5 times the median. The closest in time, other companies' Series D rounds in Tech Companies:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Tech Companies | 29 Apr 2026 | $150M | $2.75B | Goldman Sachs Alternatives and Bain Capital Ventures |
| Tech Companies | 22 Apr 2026 | $147M | not disclosed | not named |
| Wayve Tech Companies | 15 Apr 2026 | $60M | not disclosed | not named |
| Legora Tech Companies | 10 Mar 2026 | $550M | $5.55B | Accel |
| Tech Companies | 12 May 2026 | $120M | $670M | One Peak |
| Tech Companies | 4 Mar 2026 | $103M | not disclosed | National Wealth Fund and NVentures |
| Tech Companies | 25 Mar 2026 | $100M | not disclosed | EDBI and Asia Partners |
| Tech Companies | 25 Mar 2026 | $100M | not disclosed | EDBI and Asia Partners |
Sources
Where this comes from
Reported by 8 sources.
Questions
Frequently asked
How much did OpenEvidence raise in its Series D round?
OpenEvidence raised $250M in its Series D round, announced in Apr 2026.
Who led OpenEvidence's Series D round?
Thrive Capital and DST Global led it, with Sequoia Capital, GV, NVIDIA, Kleiner Perkins and Blackstone and 12 more.
What was OpenEvidence's valuation at the Series D round?
$12.00B post-money ($11.75B pre-money).
How does it compare with other Series D rounds in Tech Companies?
84 Series D rounds in Tech Companies within a year either side disclosed an amount; the median was $102M, and this round was 2.5 times the median.